Neuman Linda L, CMO at Spyre Therapeutics, holds ― shares in Spyre Therapeutics (Ticker: SYRE). Most recently, Neuman Linda L ― shares of Spyre Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Neuman Linda L?
The percentage of profitable transactions made by Neuman Linda L is ―.
What is the average return per transaction made by Neuman Linda L?
The average return per transaction made by Neuman Linda L is ―.
What stocks does Neuman Linda L hold?
Neuman Linda L holds: SYRE stocks.
What was Neuman Linda L’s latest transaction?
Neuman Linda L latest transaction was an Uninformative Buy of ―.
What was Neuman Linda L's most profitable transaction?
Neuman Linda L’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Neuman Linda L's role in Spyre Therapeutics?
Neuman Linda L's role in Spyre Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.